The list below displays information about clinical trials sponsored by Ipsen.
Only interventional studies that have started within the last 20 years and completed within the 2 last years will be displayed.
The study results will be available on ClinicalTrials.gov from 12 months after the end of the study.
Filters
Condition
Status
Phase
Country
Showing : 1 – 5 of 144 clinical trials
Dysport
Czechia
Canada
Netherlands (Kingdom of the)
Korea (the Republic of)
Italy
Turkey
United States of America (the)
Poland
Romania
Portugal
Malaysia
Terminated
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic…
The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units [U] and 800 U), compared to placebo in…
Urinary Incontinence
Overactive Bladder
Dysport
Czechia
Canada
Netherlands (Kingdom of the)
Korea (the Republic of)
Italy
Turkey
United States of America (the)
Poland
Romania
Portugal
Malaysia
Terminated
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic…
The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units [U] and 800 U), compared to placebo in…
Prostate Cancer
Decapeptyl
Belgium
Spain
Netherlands (Kingdom of the)
Lithuania
Czechia
France
Germany
Recruiting
Effects of triptorelin when given every 6-months under the skin…
The aim of the study is to determine if triptorelin formulated for use every 6 months (given twice during the study) is effective and safe for when given by injection…
Acromegaly
BIM23B065
Bulgaria
Belarus
Hungary
Ukraine
Serbia
Belgium
Terminated
Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects…
The purpose of the protocol is evaluate the safety, the pharmacodynamics and the pharmacokinetic of repeated administration of BIM23B065 in subjects with acromegaly.
IPN10200
Germany
France
Active, Not Recruiting
A Study to Assess the Safety and Efficacy of IPN10200…
The purpose of this study is to assess the safety and efficacy profile of increasing doses of IPN10200 in comparison to placebo, with the aim to discover the doses(s) that…